Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plcverified

JAZZ

Price:

$166.91

Market Cap:

$10.14B

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in narcolepsy patients seven years of age and older; Sunosi for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea; Erwinaze to tr...[Read more]

Industry

Biotechnology

IPO Date

2007-06-01

Stock Exchange

NASDAQ

Ticker

JAZZ

The Enterprise Value as of December 2025 (TTM) for Jazz Pharmaceuticals plc (JAZZ) is 9.90B

According to Jazz Pharmaceuticals plc’s latest financial reports and current stock price. The company's current Enterprise Value is 9.90B. This represents a change of -3.02% compared to the average of 10.21B of the last 4 quarters.

Jazz Pharmaceuticals plc (JAZZ) Historical Enterprise Value (quarterly & annually)

How has JAZZ Enterprise Value performed in the past?

The mean historical Enterprise Value of Jazz Pharmaceuticals plc over the last ten years is 10.66B. The current 9.90B Enterprise Value has changed 9.19% with respect to the historical average. Over the past ten years (40 quarters), JAZZ's Enterprise Value was at its highest in in the June 2021 quarter at 16.58B. The Enterprise Value was at its lowest in in the March 2020 quarter at 6.65B.

Quarterly (TTM)
Annual

Average

10.66B

Median

10.00B

Minimum

8.26B

Maximum

14.89B

Jazz Pharmaceuticals plc (JAZZ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Jazz Pharmaceuticals plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 26.76%

Maximum Annual Enterprise Value = 14.89B

Minimum Annual Increase = -18.96%

Minimum Annual Enterprise Value = 8.26B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202411.36B-5.84%
202312.07B-18.96%
202214.89B13.12%
202113.17B26.76%
202010.39B8.14%
20199.61B10.14%
20188.72B-5.98%
20179.28B12.31%
20168.26B-6.21%
20158.81B-15.65%

Jazz Pharmaceuticals plc (JAZZ) Average Enterprise Value

How has JAZZ Enterprise Value performed in the past?

The current Enterprise Value of Jazz Pharmaceuticals plc (JAZZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

12.78B

5-year avg

12.38B

10-year avg

10.66B

Jazz Pharmaceuticals plc (JAZZ) Enterprise Value vs. Peers

How is JAZZ’s Enterprise Value compared to its peers?

Jazz Pharmaceuticals plc’s Enterprise Value is greater than Avidity Biosciences, Inc. (9.15B), greater than Caris Life Sciences, Inc. (7.24B), greater than Merus N.V. (6.93B), less than Madrigal Pharmaceuticals, Inc. (12.93B), greater than Abivax S.A. (7.28B), greater than Cytokinetics, Incorporated (8.73B), greater than Halozyme Therapeutics, Inc. (8.49B), greater than Rhythm Pharmaceuticals, Inc. (7.15B), greater than Nuvalent, Inc. (7.65B), greater than Axsome Therapeutics, Inc. (7.35B),

Build a custom stock screener for Jazz Pharmaceuticals plc (JAZZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jazz Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jazz Pharmaceuticals plc (JAZZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jazz Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Jazz Pharmaceuticals plc's Enterprise Value?

What is the highest Enterprise Value for Jazz Pharmaceuticals plc (JAZZ)?

What is the 3-year average Enterprise Value for Jazz Pharmaceuticals plc (JAZZ)?

What is the 5-year average Enterprise Value for Jazz Pharmaceuticals plc (JAZZ)?

How does the current Enterprise Value for Jazz Pharmaceuticals plc (JAZZ) compare to its historical average?